國家衛生研究院 NHRI:Item 3990099045/13448

NHRI > National Institute of Infectious Diseases and Vaccinology > Shih-Jen Liu > Periodical Articles > Item 3990099045/13448

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13448

Title:	DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
Authors:	Chai, KM;Tzeng, TT;Shen, KY;Liao, HC;Lin, JJ;Chen, MY;Yu, GY;Dou, HY;Liao, CL;Chen, HW;Liu, SJ
Contributors:	National Institute of Infectious Diseases and Vaccinology
Abstract:	The development of efficient vaccines against COVID-19 is an emergent need for global public health. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major target for the COVID-19 vaccine. To quickly respond to the outbreak of the SARS-CoV-2 pandemic, a nucleic acid-based vaccine is a novel option, beyond the traditional inactivated virus vaccine or recombinant protein vaccine. Here, we report a DNA vaccine containing the spike gene for delivery via electroporation. The spike genes of SARS-CoV and SARS-CoV-2 were codon optimized for mammalian cell expression and then cloned into mammalian cell expression vectors, called pSARS-S and pSARS2-S, respectively. Spike protein expression was confirmed by immunoblotting after transient expression in HEK293T cells. After immunization, sera were collected for antigen-specific antibody and neutralizing antibody titer analyses. We found that both pSARS-S and pSARS2-S immunization induced similar levels of antibodies against S2 of SARS-CoV-2. In contrast, only pSARS2-S immunization induced antibodies against the receptor-binding domain of SARS-CoV-2. We further found that pSARS2-S immunization, but not pSARS-S immunization, could induce very high titers of neutralizing antibodies against SARS-CoV-2. We further analyzed SARS-CoV-2 S protein-specific T cell responses and found that the immune responses were biased toward Th1. Importantly, pSARS2-S immunization in hamsters could induce protective immunity against SARS-CoV-2 challenge in vivo. These data suggest that DNA vaccination could be a promising approach for protecting against COVID-19.
Date:	2021-05-27
Relation:	PLoS Neglected Tropical Diseases. 2021 May 27;15(5):Article number e0009374.
Link to:	http://dx.doi.org/10.1371/journal.pntd.0009374
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1935-2735&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000664506600006
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85106975725
Appears in Collections:	[Shih-Jen Liu] Periodical Articles [Hsin-Wei Chen] Periodical Articles [Ching-Len Liao] Periodical Articles [Horng-Yunn Dou] Periodical Articles [Guann-Yi Yu] Periodical Articles [Tsai-Teng Tzeng] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB34043618.pdf		2174Kb	Adobe PDF	258	View/Open

Loading...